Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment

References

• 1991 (AAN criteria) American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS task force. Neurology 41: 778–785.
   Google Scholar
• 1996 (AAN criteria). American Academy of Neurology AIDS Task Force. 1996. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology 47: 1247–1253.
   Google Scholar
• Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001; 103: 373–383
   PubMed Web of Science ®Google Scholar
• Anderson E, Zink W, Xiong H, Gendelman HE. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr 2002; 31(Suppl 2)S43–S54
   Google Scholar
• Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69: 1789–1799
   PubMed Web of Science ®Google Scholar
• Arroyo MA, Tien H, Pagán M, Swanstrom R, Hillyer GV, Cadilla CL, Meléndez- Guerrero LM. Virologic risk factors for vertical transmission of HIV type 1 in Puerto Rico. AIDS Res Hum Retroviruses 2002; 18: 447–460
   PubMed Web of Science ®Google Scholar
• Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 2004; 16: 1–13
   PubMed Web of Science ®Google Scholar
• Beyer S, Walter Y, Hellmann J, Kramer PJ, Kopp-Schneider A, Kroeger M, Ittrich C. Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF-MS spectra. J Proteome Res 2006; 5: 254–261
   PubMed Web of Science ®Google Scholar
• Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. The NF-kappaB-mediated control of ROS and JNK signaling. Histol Histopathol 2006; 21: 69–80
   PubMed Web of Science ®Google Scholar
• Carlson KA, Ciborowski P, Schellpeper CN, Biskup TM, Shen RF, Luo X, Destache CJ, Gendelman HE. Proteomic fingerprinting of HIV-1-infected human monocyte-derived macrophages: a preliminary report. J Neuroimmunol 2004; 147: 35–42
   PubMed Web of Science ®Google Scholar
• Chen W, Tang Z, Fortina P, Patel P, Addya S, Surrey S, Acheampong EA, Mukhtar M, Pomerantz RJ. Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways. Virology 2005; 334: 59–73
   PubMed Web of Science ®Google Scholar
• Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW, Jr, Sowder RC, 2nd, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE 2006. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol 80: 9039–9052.
   PubMed Web of Science ®Google Scholar
• Ciborowski P, Kadiu I, Rozek W, Smith L, Bernhardt K, Fladseth M, Ricardo-Dukelow M, Gendelman HE. Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome. Virology 2007; 363: 198–209
   PubMed Web of Science ®Google Scholar
• Gartner S. HIV infection and dementia. Science 2000; 287: 602–604
   PubMed Web of Science ®Google Scholar
• Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 1988; 167: 1428–1441
   PubMed Web of Science ®Google Scholar
• Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R. The neuropathogenesis of the AIDS dementia complex. AIDS (Suppl A) 1997; 11: S35–S45
   Google Scholar
• Glanzer JG, Enose Y, Wang T, Kadiu I, Gong N, Rozek W, Liu J, Schlautman JD, Ciborowski PS, Thomas MP, Gendelman HE. Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation. J Neurochem. 2007; 102: 622–645
   Google Scholar
• Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005; 5: 69–81
   PubMed Web of Science ®Google Scholar
• Holguin A, Frank MG, Biedenkapp JC, Nelson K, Lippert D, Watkins LR, Rudy JW, Maier SF. Characterization of the temporo-spatial effects of chronic bilateral intrahippocampal cannulae on interleukin-1beta. J Neurosci Methods 2007; 161: 265–272
   Google Scholar
• Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002; 18(Suppl 1)S96–S104
   PubMedGoogle Scholar
• Kadiu I, Ricardo-Dukelow M, Ciborowski P, Gendelman HE. Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells. J Immunol 2007; 178: 6404–6415
   PubMed Web of Science ®Google Scholar
• Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab 2007; 27: 123–134
   PubMed Web of Science ®Google Scholar
• Laspiur JP, Anderson ER, Ciborowski P, Wojna V, Rozek W, Duan F, Mayo R, Rodríguez E, Plaud-Valentín M, Rodríguez-Orengo J, Gendelman HE, Meléndez LM. CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol 2007; 192: 157–170
   PubMed Web of Science ®Google Scholar
• Lee C, Liu QH, Tomkowicz B, Yi Y, Freedman BD, Collman RG. Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. J Leukoc Biol 2003; 74: 676–682
   PubMed Web of Science ®Google Scholar
• Li W, Galey D, Mattson MP, Nath A. Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotox Res 2005; 8: 119–134
   PubMed Web of Science ®Google Scholar
• Luo X, Carlson KA, Wojna V, Mayo R, Biskup TM, Stoner J, Anderson J, Gendelman HE, Melendez LM. Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 2003; 60: 1931–1937
   PubMed Web of Science ®Google Scholar
• McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol 2004; 157: 3–10
   PubMed Web of Science ®Google Scholar
• McArthur JC, Sacktor N, Selnes O. Human immunodeficiency virus-associated dementia. Semin Neurol 1999; 19: 129–150
   PubMed Web of Science ®Google Scholar
• Munoz LE, Franz S, Pausch F, Furnrohr B, Sheriff A, Vogt B, Kern PM, Baum W, Stach C, von Laer D, Brachvogel B, Poschl E, Herrmann M, Gaipl US. The influence on the immunomodulatory effects of dying and dead cells of annexin V. J Leukoc Biol 2007a; 81: 6–14
   PubMed Web of Science ®Google Scholar
• Nieves DM, Plaud M, Wojna V, Skolasky R, Melendez L. Characterization of peripheral blood human immunodeficiency virus isolates from Hispanic women with cognitive impairment. J NeuroVirol 2007; 13: 315–327
   Google Scholar
• Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, Apweiler R, Haab BB, Simpson RJ, Eddes JS, Kapp EA, Moritz RL, Chan DW, Rai AJ, Admon A, Aebersold R, Eng J, Hancock WS, Hefta SA, Meyer H, Paik YK, Yoo JS, Ping P, Pounds J, Adkins J, Qian X, Wang R, Wasinger V, Wu CY, Zhao X, Zeng R, Archakov A, Tsugita A, Beer I, Pandey A, Pisano M, Andrews P, Tammen H, Speicher DW, Hanash SM. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005; 5: 3226–3245
   PubMed Web of Science ®Google Scholar
• Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997; 158: 3499–3510
   PubMed Web of Science ®Google Scholar
• Renta JY, Cadilla CL, Vega ME, Hillyer GV, Estrada C, Jiménez E, Abreu E, Méndez I, Gandía J, Meléndez-Guerrero LM. Longitudinal studies on maternal HIV-1 variants by biological phenotyping, sequence analysis and viral load. Cell Mol Biol (Noisy-le-grand) 1997; 43: 1097–1114
   Google Scholar
• Reynolds A, Laurie C, Mosley RL, Gendelman HE. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 2007; 82: 297–325
   PubMed Web of Science ®Google Scholar
• Schafer U, Seibold S, Schneider A, Neugebauer E. Isolation and characterisation of the human rab18 gene after stimulation of endothelial cells with histamine. FEBS Lett 2000; 466: 148–154
   Google Scholar
• Self RL, Mulholland PJ, Nath A, Harris BR, Prendergast MA. The human immunodeficiency virus type-1 transcription factor Tat produces elevations in intracellular Ca2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site. Brain Res 2004; 995: 39–45
   PubMed Web of Science ®Google Scholar
• Stehlik C, Fiorentino L, Dorfleutner A, Bruey JM, Ariza EM, Sagara J, Reed JC. The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. J Exp Med 2002; 196: 1605–1615
   PubMed Web of Science ®Google Scholar
• Storey JD. The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat 2003; 31: 2013–2035
   Web of Science ®Google Scholar
• Sun B, Rempel HC, Pulliam L. Loss of macrophage-secreted lysozyme in HIV-1 associated dementia detected by SELDI-TOF mass spectrometry. AIDS 2004; 18: 1009–1012
   Google Scholar
• Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene 2005; 24: 7567–7578
   PubMed Web of Science ®Google Scholar
• Vazquez N, Greenwell-Wild T, Marinos NJ, Swaim WD, Nares S, Ott DE, Schubert U, Henklein P, Orenstein JM, Sporn MB, Wahl SM. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J Virol 2005; 79: 4479–4491
   PubMed Web of Science ®Google Scholar
• Velásquez I, Plaud M, Perez Laspiur J, Wojna V, Skolasky R, Ciborowski P, Gendelman HE, Melendez LM. Dysregulation of Cu/Zn superoxide dismutase-1 in the CSF and monocytes of Hispanic women with cognitive impairment. J NeuroVirol 2007; 13(Suppl 1)131
   Google Scholar
• Wahl SM, Greenwell-Wild T, Peng G, Ma G, Orenstein JM, Vazquez N. Viral and host cofactors facilitate HIV-1 replication in macrophages. J Leukoc Biol 2003; 74: 726–735
   PubMed Web of Science ®Google Scholar
• Wojna V, Carlson KA, Luo X, Mayo R, Meléndez LM, Kraiselburd E, Gendelman HE. Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: a case study. J NeuroVirol 2004; 10(Suppl 1)74–81
   PubMedGoogle Scholar
• Wojna V, Skolasky RL, Hechavarria R, Mayo R, Selnes O, McArthur JC, Melendez LM, Maldonado E, Zorrilla CD, Garcia H, Kraiselburd E, Nath A. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J NeuroVirol 2006; 12: 356–364
   PubMed Web of Science ®Google Scholar
• Xie Q, Tianxin L, Zhang Y, Zheng J, Bonanno JA. Molecular cloning and characterization of a human AIF-like gene with ability to induce apoptosis. J Biol Chem 2005; 280: 19673–19681
   Google Scholar
• Zhang M, Li X, Pang X, Ding L, Wood O, Clouse K, Hewlett I, Dayton AI. Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. J Biomed Sci 2001; 8: 290–296
   Google Scholar
• Zybarth G, Reiling N, Schmidtmayerova H, Sherry B, Bukrinsky M. Activation-induced resistance of human macrophages to HIV-1 infection in vitro. J Immunol 1999; 162: 400–406
   Google Scholar